ESG

With its Phase 1 trial fully enrolled, Senti Bio’s logic-gated CAR-NK therapy shows deep, durable remissions, charting an expedited path for R/R AML.

Bio-Techne promotes Steve Crouse to lead its high-growth Diagnostics and Spatial Biology unit, signaling a strategic focus on innovation after a key divestiture.

A new AI-powered infrared system promises to prevent catastrophic industrial accidents and save billions by predicting equipment failures before they happen.

Wesley Pharmaceuticals launches a 503B-compliant NAD+ injection, promising quality in the booming anti-aging market amid scientific debate over its efficacy.

Amid a national organ shortage, a Virginia organization's use of new tech and community campaigns led to a 27.5% jump in organs transplanted since 2021.

A surge in healthcare job applications offers a prime opportunity, but new data reveals a critical bottleneck preventing companies from turning interest into hires.

A new AI-powered solution from Emburse promises to transform expense management by catching errors and fraud before reports are even submitted.

Krikey AI's new tool turns text into 3D social media videos, aiming to democratize animation and disrupt the creator economy. Is this the future of content?

Blink Charging and BetterFleet unite to offer a turnkey solution using AI and digital twins, aiming to de-risk and streamline EV fleet electrification.

At a key summit, Candel Therapeutics will showcase how its oncolytic virus, CAN-3110, uses biomarkers to fight one of the deadliest brain cancers.

As a wave of old solar panels looms, Comstock Inc. is betting on a certified zero-landfill recycling facility. Can this green venture save its financials?

For the sixth straight year, Trex is America's most trusted decking. We explore how product innovation, sustainability, and market savvy keep it on top.

Insight Molecular Diagnostics secures $26M to expand its transplant rejection test to the heart market, backed by a major shareholder amid market dilution concerns.

Global tech firm Mastek deepens its UK roots with a new Leeds AI hub, boosting the region's economy and tackling the digital skills gap.

Lantern's expanded cancer solution uses NCI-level expertise and community care to promise better outcomes and a significant return on investment for employers.

SOFIE Biosciences' FAPI-PRO trial begins, testing a novel radiotracer that could revolutionize the detection of one of the deadliest forms of cancer.

New 3D human tissue models show groundbreaking promise in predicting toxicity for advanced cancer therapies, heralding a major shift away from animal testing.

AI voice leader ElevenLabs' new insurance for its agents, a first of its kind, aims to solve the liability crisis hindering enterprise AI adoption.

The new partnership between Manchester City and EV giant BYD is more than a sponsorship—it's a strategic play for European dominance and a new model for sustainability.

As OneSpaWorld prepares its Q4 results, all eyes are on the wellness giant as a barometer for luxury travel spending and its tech-driven future.